April 23, 2025. More for You ...

The FDA announced a plan to get rid of eight petroleum-based artificial colors from the nation's food supply, such as red dye ...

A local health care provider is leading a statewide organization. Dr. Edward Hosbach of Mercer Health was recently inducted as the president of the Ohio Osteopathic Association. During the Ohio ...

WW International shares are trading higher by 79% during Tuesday's session. The company announced a new partnership with Eli ...

Eli Lilly (LLY) will report Q1 results on Thursday. Analysts expect in line results with focus on tirizepatide and obesity franchise.

Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps reduce your appetite by influencing two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

No, this isn’t some late-night infomercial fantasy — it’s the reality of Zepbound, and it’s changing everything about how we approach weight loss. While you’ve been cycling through diets ...

This is partly thanks to Zepbound, a weight loss medicine that's already generating more than $1 billion in quarterly sales, although it was approved only in late 2023. Zepbound's prospects still ...

iPhone colors may not matter much to some, but for plenty of users, they have the power to sway an upgrade decision. And with this year’s iPhone 17 lineup, we could see bigger color changes than ...

Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its diabetes treatment Mounjaro, the company's latest attempt ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...